<DOC>
	<DOC>NCT02028169</DOC>
	<brief_summary>This post marketing observational study (PMOS) is designed to provide the initial data on work impairment of Psoriatic Arthritis (PsA) patients in Turkey, as well as changes in work impairment, life quality and clinical response during treatment with anti-TNF agents.</brief_summary>
	<brief_title>To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Psoriatic</mesh_term>
	<criteria>Actively working, either fulltime or parttime Previous confirmed diagnosis of PsA by a rheumatologist Patients for whom the physician has initiated PsA treatment with an AntiTNF in accordance with Turkish Ministry of Health regulations and reimbursement criteria Able to provide authorization to use and disclose their health related information Patients with a history of an allergic reaction or significant sensitivity to antiTNF agents Patients with possible followup problems during the planned study period or patients who may not be compliant to treatment as evaluated by the investigator/treating physician Patients participating in any clinical trial of an experimental drug 30 days prior to the first visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Work Productivity</keyword>
	<keyword>Anti-TNFs</keyword>
	<keyword>Psoriatic Arthritis</keyword>
</DOC>